Related Experiment Video
Updated: Jun 2, 2026
12:31
In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
Phenotype mining in CNV carriers from a population cohort
Olli P H Pietiläinen1, Karola Rehnström, Eveliina Jakkula
1Institute for Molecular Medicine Finland, and Department of Medical Genetics, University of Helsinki, Helsinki, Finland.
Human Molecular Genetics
|April 21, 2011
Summary
Phenotype mining links genetic variation to traits like intellectual deficits. This novel approach identified neurodevelopmental issues associated with large genetic deletions in a large population cohort.
Area of Science:
- Genetics
- Bioinformatics
- Population Health
Background:
- Understanding the genetic basis of complex traits is challenging.
- Phenotype mining offers a novel approach to link genetic variation with observable traits.
Purpose of the Study:
- To implement and evaluate phenotype mining for identifying genetic underpinnings of phenotypic variation.
- To explore the association between genetic variation and neurodevelopmental traits.
Main Methods:
- Utilized phenotype mining by searching phenotype databases for measures correlated with genetic variation.
- Analyzed the Northern Finland 1966 Birth Cohort (NFBC1966) for genome-wide genotyping and sequencing data.
- Investigated associations between large deletions (>500 kb) and specific traits.
Main Results:
- Identified neurodevelopment-related traits (intellectual deficits, poor school performance, hearing abnormalities) associated with large deletions.
- Observed shared single nucleotide polymorphism haplotypes around deletions, suggesting shared ancestry.
Conclusions:
- Phenotype mining is effective in elucidating the genetic basis of complex phenotypic variation.
- The findings suggest potential for expanding phenotype mining to broader populations.
Related Concept Videos
02:26Comparing Copy Number Variations and SNPs
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
02:46Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
01:35Pedigree Analysis
Overview